-fetoprotein (AFP), an extensively used tumor marker in clinical practice, is not an appropriate biomarker for hepatocellular carcinoma diagnosis, on account of its low sensitivity and poor specificity
Cell Physiol Biochem (2017) 42:50618
Heterogeneity of Melanoma and TME: Variability among patients tumors and TMEs can limit the broad applicability of certain nanoplatforms, necessitating personalized or adaptable approaches
The research in these areas is sparse, but the excitement that these therapies generate is great, and we will discuss the risks and benefits of treatment with you before your surgery
03 Metabolism & Wellness Support B12 supports metabolic function and overall wellness, making it a helpful addition to a personalized health and vitality plan
The confirmed harms were a small increase in liver enzymes, a roughly 1% incidence of muscle symptoms, and a modest rise in blood sugar in patients already near the diabetes threshold